Skip to main content
. 2021 Oct 22;47(12):1368–1392. doi: 10.1007/s00134-021-06531-x
Recommendation
We suggest not using high-dose IV TXA in critically ill patients with gastrointestinal bleeding (Conditional recommendation, high certainty evidence).
We make no recommendation regarding the use of low-dose IV TXA or enteral TXA in critically ill patients with gastrointestinal bleeding (No recommendation, moderate certainty evidence).